Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 28 | 0 | 7 | 0 | 126,90 € | 140,34 € | 10,59 % |
| Merit Medical Systems | 17 | 0 | 5 | 0 | 74,50 € | 86,90 € | 16,64 % |
| CONMED Corp. | 12 | 1 | 4 | 0 | 65,00 € | 106,18 € | 63,35 % |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | 101,80 € | 184,92 € | 81,65 % |
| Icon plc | 18 | 0 | 3 | 0 | 292,80 € | 319,67 € | 9,18 % |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | 139,65 € | 236,30 € | 69,21 % |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | 40,06 € | 50,33 € | 25,64 % |
| Insulet Corp. | 16 | 0 | 3 | 0 | 154,10 € | 215,54 € | 39,87 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 38,00 € | 84,74 € | 123,01 % |
| LivaNova plc | 9 | 0 | 3 | 0 | 57,00 € | 66,59 € | 16,83 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 362,30 € | 421,61 € | 16,37 % |
| United Therapeutics | 18 | 0 | 3 | 0 | 245,40 € | 288,66 € | 17,63 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,85 € | 26,01 € | 31,05 % |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | 75,50 € | 75,94 € | 0,58 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | 31,00 € | 38,99 € | 25,77 % |
| Xencor Inc. | 10 | 1 | 2 | 0 | 22,60 € | 32,58 € | 44,15 % |
| Masimo Corp. | 7 | 1 | 2 | 0 | 113,00 € | 147,62 € | 30,63 % |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | 109,00 € | 116,99 € | 7,33 % |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | 28,20 € | 41,81 € | 48,28 % |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | 1,63 € | 3,70 € | 126,99 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 151,00 € | 184,76 € | 22,36 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 99,02 € | - | - |
| Amedisys Inc. | 14 | 0 | 1 | 0 | 89,00 € | 92,26 € | 3,66 % |
| Korian S.A. | 1 | 0 | 1 | 0 | 3,55 € | - | - |
| Myriad Genetics | 6 | 2 | 1 | 0 | 23,20 € | 25,14 € | 8,38 % |